Amyris (AMRSQ) Akcija Цена

Amyris Цена

NASDAQ·ZATVORENO
0,00
​
Tržište je zatvoreno

U poslednjih 17 godina prihod Amyris rastao je 31,7 % godišnje i dostigao 269,85 М USD. Za Amyris neto marža od -195,9 % je porasla u odnosu na -350,8 % pre nekoliko godina.

Cena akcije Amyris

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Amyris poslovni model i analiza akcije

Amyris Inc. je kompanija sa sedištem u SAD-u koja se specijalizovala za proizvodnju održivih proizvoda. Osnovana je 2003. godine, a sedište joj se nalazi u Emeryvilleu u Kaliforniji. Kompanija teži promociji održivosti u svakodnevnom životu i smanjenju zavisnosti od fosilnih goriva. Poslovni model Amyris-a zasnovan je na otkrivanju i razvoju bioloških mikroorganizama sposobnih da pretvore šećere i druge ugljene hidrate u vredne proizvode kao što su goriva, hemikalije i aroma. Ova tehnologija, poznata kao sintetička biologija, prvi put je korišćena za proizvodnju artemisinina, koji se koristi protiv malarije. Tokom vremena, Amyris je proširila svoj portfolijo i specijalizovala se za proizvodnju održivih proizvoda za industriju kozmetike, bio-goriva, hrane i hemijske industrije. Vodeći proizvodi uključuju Biosolve, ekološki prihvatljivo rastvarač za industrijsko čišćenje, Neossance, biljni hidratant za kozmetičku industriju i Biofene, bio-bazirano gorivo. Za proizvodnju svojih proizvoda, kompanija je formirala partnerstva sa raznim organizacijama širom sveta. Na primer, sklopila je partnerstvo sa francuskom kompanijom Total kako bi osnovala zajednička ulaganja za proizvodnju bio-goriva. Amyris je takođe proširila svoje poslovanje razvojem platforme za sintetičku biologiju koja omogućava drugim igračima u industriji da razvijaju prilagođene organizme za procese proizvodnje. Ovaj novi poslovni model doveo je kompaniju u nova tržišta, kao što su medicinska i energetska sektora. U 2020. godini, pandemija COVID-19 predstavljala je izazove za kompaniju jer je potražnja za nekim proizvodima opala. U odgovoru, Amyris je preusmerila svoju proizvodnju na dezinfekciona sredstva kako bi zadovoljila povećanu potražnju za ovim proizvodima. U celosti, Amyris je postala vodeća kompanija u održivoj proizvodnji i posvećena je promociji inovacija u sintetičkoj biologiji radi pozitivnog uticaja na okruženje.

Često postavljana pitanja o akciji Amyris

Amyris Inc is a leading biotechnology company focused on sustainable ingredients for various industries. Their business model revolves around the production and commercialization of high-performance sustainable products. With a strong emphasis on innovation, Amyris utilizes its proprietary synthetic biology platform to engineer microbes and produce sustainable alternatives to petroleum-derived chemicals. These include renewable ingredients for cosmetics, fragrances, flavors, and nutraceuticals, as well as renewable feedstocks for the production of renewable diesel and jet fuels. By enabling the transition to a more sustainable economy, Amyris Inc aims to deliver environmental benefits while providing quality products to its customers.

Amyris Inc is primarily active in the renewable chemicals and sustainable fuels industries.

The main competitors of Amyris Inc in the market are Evolva Holding SA, Synthetic Genomics Inc, and Intrexon Corporation.

Amyris Inc. is a leading biotechnology company known for its sustainable solutions in the fields of health and wellness, clean beauty, and renewable chemicals. Founded in 2003, Amyris has a rich history marked by its commitment to advancements in synthetic biology. The company's groundbreaking research has enabled the production of a wide range of innovative products, including sustainable ingredients, fragrances, and high-performance materials. Amyris has collaborated with numerous partners and has expanded its global presence, ensuring the adoption of its renewable solutions worldwide. With a strong focus on environmental and societal well-being, Amyris Inc. continues to revolutionize industries through sustainable, nature-inspired innovations.

Amyris Inc has achieved several significant milestones in its trajectory. Notably, the company successfully developed and commercialized its proprietary yeast strain technology, enabling the production of high-value molecules more sustainably. Amyris Inc also established strategic partnerships with various global leaders, expanding its product portfolio and market reach. Additionally, the company made remarkable progress in the renewable energy sector, delivering renewable diesel and jet fuel solutions. Amyris Inc's commitment to sustainability and innovation has garnered accolades, including recognition as a Fast Company Most Innovative Company and a World Economic Forum Technology Pioneer. The company's continuous growth and advancements solidify its position as an industry leader in sustainable solutions.

Amyris Inc is primarily present in countries and regions across the globe, including the United States, Brazil, Europe, and Asia.

Amyris Inc represents a set of core values and corporate philosophy that drive its business operations. The company is committed to delivering sustainable solutions through its advanced biotechnology platform. Amyris focuses on providing renewable products across various industries, including clean beauty, flavors, fragrances, and sweeteners. With an emphasis on innovation, Amyris strives to create high-performance products, enhancing the quality of life while minimizing the environmental impact. The company's dedication to scientific excellence, integrity, and social responsibility enables Amyris to fulfill its mission of positively transforming the world. Amyris Inc consistently pursues its goal of sustainable development and improving global resource efficiency through innovative biotechnology solutions.

8 analitičara trenutno ocenjuje akciju Amyris: 0 preporučuje kupovinu, 3 držanje i 5 prodaju.

Po trenutnom kursu akcija Amyris kotira 0,00 EUR (0,00 USD).

Akcija Amyris (AMRSQ) kotira na 5 berze, uključujući: NASDAQ (AMRS), SIX (Zürich) (3A01.SW), Frankfurt (3A01.F), München (3A01.MU), Düsseldorf (3A01.DU).

Amyris Inc. is an American biotechnology company based in Emeryville, California. Founded in 2003, the company specializes in the development and production of molecules that can serve as the basis for a variety of products, particularly in the cosmetics, skincare, body and hair care, perfume, and fragrance industries. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the construction and optimization of microorganisms capable of producing specific molecules, such as essential oils, fats and waxes, sugars, flavors, and other compounds, from sustainable raw materials. The company's focus is on producing molecules from renewable resources such as sugarcane, corn, cellulose, and other bio-based materials. The molecules produced by Amyris are used either directly as end products or as ingredients in other products. Amyris has several divisions, including "Ingredients," "Cosmetics & Personal Care," "Fragrances & Flavors," and "Sweeteners & Nutraceuticals." In the "Ingredients" division, the company produces a variety of molecules that can be used as starting materials for the production of cosmetics and personal care products, cleaning agents, lubricants, and other products. Examples of products include squalene, hyaluronic acid, vitamin E, ferulic acid, caprylic/capric triglycerides, and others. In the "Cosmetics & Personal Care" division, Amyris also offers its own skincare, body, and hair care products based on sustainable, organic ingredients. These include nourishing facial oils, moisturizers, cleansers, shampoos, conditioners, and others. In the "Fragrances & Flavors" division, Amyris produces essential oils, flavors, and fragrances that are used in a variety of applications, including perfumes, room fragrances, scented candles, and aromatherapy products. Key products include lavender oil, cinnamon bark oil, lemon oil, vanillin, and others. Finally, Amyris also offers products in the "Sweeteners & Nutraceuticals" category, including plant-based sweeteners such as rebaudioside A and others, as well as dietary supplements based on omega-3 fatty acids, vitamin D3, and other ingredients. Amyris Inc.'s business model is based on the use of innovative biotechnology platforms for the development and production of molecules that can be used as raw materials for a variety of products. By using sustainable raw materials and producing molecules in an environmentally friendly way, the company has established itself as a pioneer in sustainable chemistry. With a wide range of products and a strong presence in global markets, Amyris Inc. is well positioned to continue growing in the coming years and promote awareness of sustainable innovations in the chemical industry.

Prihod se trenutno ne može izračunati za Amyris.

Dobit se trenutno ne može izračunati za Amyris.

KGV se trenutno ne može izračunati za Amyris.

KUV se trenutno ne može izračunati za Amyris.

Eulpool score kvaliteta za Amyris je 8/10.

ISIN za Amyris je US03236M2008. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

WKN za Amyris je A2DS41. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.

Ticker za Amyris je AMRSQ. Simbol tikera se koristi za trgovinu akcijama Amyris na berzanskom tržištu.

Фер вредностTerminal
0,00 USD
Над-/ПодцењеностTerminal
Адекватно вредна
Сектор
Индустрија
Хемикалије
Број акција
Запослени
Приход по запосленом
453.524,37 USD
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт amyris.com
Валута
USD
Јавна понуда
28. сеп 2010.
ISIN
US03236M2008
CUSIP
03236M200
SEDOL
BF0FLW8
Тржишна капитализација
Опсег од 52 недеље
AAQS
8 / 10
PEG
—
P/E однос
P/Ee 2023
—
P/Ee 2024
—
P/Ee 2025
-0,01
P/Ee 2026
—
P/Ee 2027
—
P/S
P/Se
0,00
EV/EBIT
—
P/B однос
0,00
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
-183,16 %
Zadnje ažurirano 22. нов 2026. 20:53

Amyris Peer grupa

Amyris Тикер

DISELORF · 3A01.DUFRANKFURT · 3A01.FMINHEN · 3A01.MUNASDAQ · AMRSSIX · 3A01.SW

Amyris FIGI

AMRSQ:US · BBG000DW5XK4AMRSQ:PQ · BBG000DW75P8AMRSQ:UV · BBG000DW76853A01:GR · BBG0016VVS153A01:GS · BBG0016VVS513A01:GB · BBG0016VVS79AMRSEUR:EO · BBG00C0L7JL4AMRSEUR:XH · BBG00C0L7JW2AMRSEUR:XF · BBG00C0L7K04AMRSEUR:XE · BBG00C0L7K40AMRSEUR:XJ · BBG00C0L7K68AMRSEUR:XL · BBG00C0L7K86

Sve ključne metrke i detaljne analize Amyris u dubinskoj analizi

Naša analiza akcija za akciju Amyris uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Amyris. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: